Literature DB >> 29738769

Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis.

Yufu Wang1, Tianyi Fang1, Lining Huang1, Hao Wang1, Lei Zhang2, Zhidong Wang3, Yunfu Cui4.   

Abstract

CD177 is considered to represent neutrophils. We analyzed mRNA expression level of CD177 and clinical follow-up survey of PDAC to estimate overall survival (OS) from Gene Expression Omnibus (GEO) dataset (GSE21501, containing samples from 102 PDAC patients) by R2 platform (http://r2.amc.nl). We also analyzed correlated genes of CD177 by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis to predict the potential relationship between neutrophils and prognosis of PDAC. We then performed hematoxylin and eosin (H&amp;E) staining and immunohistochemical staining of surgical specimens to verify infiltration of neutrophils in PDAC tissues. After analyzing mRNA expression data and clinical follow-up survey provided in the GEO dataset (GSE21501, containing samples from 102 PDAC patients) and clinicopathological data of 23 PDAC patients, we demonstrated that CD177 was correlated with poor prognosis. The univariate Kaplan-Meier survival analysis revealed that OS was inversely associated with increased expression of CD177 (P = 0.012). Expression of phosphodiesterase (PDE)4D was positively related to CD177 in gene correlation analysis (R = 0.413, P < 0.001) by R2 platform. H&amp;E staining and immunohistochemistry of CD177 in 23 PDAC surgical samples showed accumulation of neutrophils in the stroma and blood vessels around the cancer cells. In addition, immunohistochemical staining showed that CD177 was highly expressed in the stroma and blood vessels around tumor tissues of PDAC, which was similar to H&amp;E staining. Expression of CD177 can be used to represent infiltration of neutrophils, which may have potential prognostic value in PDAC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD177; Inflammation; Neutrophils; Pancreatic ductal adenocarcinoma; Prognosis; RNA-Seq

Mesh:

Substances:

Year:  2018        PMID: 29738769     DOI: 10.1016/j.bbrc.2018.05.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Authors:  Shelby Lennon; Ayman Oweida; Dallin Milner; Andy V Phan; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Adam C Mueller; David Raben; Jorge L Martínez-Torrecuadrada; Todd M Pitts; Hilary Somerset; Kimberly R Jordan; Kirk C Hansen; Jason Williams; Wells A Messersmith; Richard D Schulick; Philip Owens; Karyn A Goodman; Sana D Karam
Journal:  Clin Cancer Res       Date:  2019-04-03       Impact factor: 12.531

Review 2.  Neutrophil in the Pancreatic Tumor Microenvironment.

Authors:  Lin Jin; Hong Sun Kim; Jiaqi Shi
Journal:  Biomolecules       Date:  2021-08-07

Review 3.  PDE4 subtypes in cancer.

Authors:  Samuel Hsien Lai; Guston Zervoudakis; Jesse Chou; Mark E Gurney; Kelly M Quesnelle
Journal:  Oncogene       Date:  2020-03-20       Impact factor: 9.867

4.  Tumour microenvironment and heterotypic interactions in pancreatic cancer.

Authors:  Raúl Muñoz Velasco; Ana García García; Paula Jiménez Sánchez; Inmaculada Montanuy Sellart; Víctor Javier Sánchez-Arévalo Lobo
Journal:  J Physiol Biochem       Date:  2022-02-01       Impact factor: 4.158

Review 5.  3D approaches to model the tumor microenvironment of pancreatic cancer.

Authors:  Elena Tomás-Bort; Markus Kieler; Shreya Sharma; Juliana B Candido; Daniela Loessner
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

Review 6.  Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Authors:  Verena Hofschröer; Karolina Najder; Micol Rugi; Rayhana Bouazzi; Marco Cozzolino; Annarosa Arcangeli; Gyorgy Panyi; Albrecht Schwab
Journal:  Front Pharmacol       Date:  2021-01-19       Impact factor: 5.810

Review 7.  Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer.

Authors:  Hillary G Pratt; Kayla J Steinberger; Nicole E Mihalik; Sascha Ott; Thomas Whalley; Barbara Szomolay; Brian A Boone; Timothy D Eubank
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 8.  Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment.

Authors:  Steve Robatel; Mirjam Schenk
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

9.  The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.

Authors:  Marta Toledano-Fonseca; M Teresa Cano; Elizabeth Inga; Auxiliadora Gómez-España; Silvia Guil-Luna; María Victoria García-Ortiz; Rafael Mena-Osuna; Juan R De la Haba-Rodriguez; Antonio Rodríguez-Ariza; Enrique Aranda
Journal:  Cancers (Basel)       Date:  2021-03-10       Impact factor: 6.639

Review 10.  The Immune Microenvironment in Pancreatic Cancer.

Authors:  Magdalena Huber; Corinna U Brehm; Thomas M Gress; Malte Buchholz; Bilal Alashkar Alhamwe; Elke Pogge von Strandmann; Emily P Slater; Jörg W Bartsch; Christian Bauer; Matthias Lauth
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.